In around 90 percent of PsA cases, the joint symptoms only appear after the skin manifestations. Scientific studies have shown that a delayed PsA diagnosis can have unfavorable prognostic implications. Recently published consensus recommendations therefore suggest that patients with plaque psoriasis should be screened for joint involvement once or twice a year. Various screening methods can be combined.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Case report: alveolar sarcoidosis
Acute hypoxemic respiratory failure as initial manifestation
- "Swiss Health Care Atlas"
Supply situation in Switzerland: Update
- Adrenogenital syndrome
Clinical care from birth to adulthood
- Lung cancer
Multidisciplinary teams in oncology
- Psoriasis: System therapies in everyday practice
Current real-world data at a glance
- Omega-3 fatty acids for obesity and type 2 diabetes
More fish oil for better lipid and HbA1c levels
- MASLD often goes unnoticed and is underestimated
Think tank for improving the supply situation
- DGPPN Congress